{"id":279949,"date":"2024-10-19T18:54:16","date_gmt":"2024-10-19T18:54:16","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-11138-12017-tc\/"},"modified":"2024-10-25T15:29:01","modified_gmt":"2024-10-25T15:29:01","slug":"bs-en-iso-11138-12017-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-11138-12017-tc\/","title":{"rendered":"BS EN ISO 11138-1:2017 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
67<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
68<\/td>\n | Endorsement notice <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
71<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
73<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
76<\/td>\n | 4 General manufacturing requirements 4.1 Manufacturing controls 4.1.1 Quality management systems 4.1.2 Traceability 4.1.3 Finished product requirements 4.1.4 Personnel 4.2 Test organism 4.2.1 Strain <\/td>\n<\/tr>\n | ||||||
77<\/td>\n | 4.2.2 Originating inoculum for suspension 4.2.3 Test organism count 4.3 Information to be provided by the manufacturer (labelling) <\/td>\n<\/tr>\n | ||||||
78<\/td>\n | 4.4 Storage and transport <\/td>\n<\/tr>\n | ||||||
79<\/td>\n | 5 Specific manufacturing requirements 5.1 Suspensions 5.2 Carrier, primary and secondary packaging 5.3 Inoculated carrier <\/td>\n<\/tr>\n | ||||||
80<\/td>\n | 5.4 Biological indicators 5.5 Self-contained biological indicators 6 Determination of population and resistance 6.1 General resistance requirements 6.2 Test organism 6.3 Population of test organisms <\/td>\n<\/tr>\n | ||||||
81<\/td>\n | 6.4 Resistance characteristics 6.5 Test conditions <\/td>\n<\/tr>\n | ||||||
82<\/td>\n | 7 Culture conditions 7.1 Incubator 7.2 Growth medium 7.3 Incubation <\/td>\n<\/tr>\n | ||||||
83<\/td>\n | 7.4 Software validation 7.5 Incubation time using detection system <\/td>\n<\/tr>\n | ||||||
84<\/td>\n | Annex\u00a0A (normative) Determination of viable count <\/td>\n<\/tr>\n | ||||||
86<\/td>\n | Annex\u00a0B (normative) Determination of growth inhibition by carriers and primary packaging materials exposed to sterilization processes <\/td>\n<\/tr>\n | ||||||
89<\/td>\n | Annex\u00a0C (normative) D value determination by survivor curve method <\/td>\n<\/tr>\n | ||||||
93<\/td>\n | Annex\u00a0D (normative) D value determination by fraction negative method <\/td>\n<\/tr>\n | ||||||
109<\/td>\n | Annex\u00a0E (normative) Survival-kill response characteristics <\/td>\n<\/tr>\n | ||||||
111<\/td>\n | Annex\u00a0F (informative) Relationship between components of biological indicators <\/td>\n<\/tr>\n | ||||||
112<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Sterilization of health care products. Biological indicators – General requirements<\/b><\/p>\n |